2018 International Congress » Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

1:45pm-3:15pm

[18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment

KB. Lee, YJ. Park, C. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm

18F-FDG PET brain in Parkinsonism

F. Amod (Durban, South Africa)

1:45pm-3:15pm

91 years old woman with Sjogren’s syndrome and Parkinsonism

M. Augusto, PV. Perin (Atibaia, Brazil)

1:45pm-3:15pm

A case of levodopa responsive rapid onset dystonia-parkinsonism

Y. Fernandez, S. Frucht (New York, NY, USA)

1:45pm-3:15pm

A Case of Parkinsonism due to the Hypoxic-Ischemic Lesions of the Striatum

H. Kaleagasi, N. Oksuz, O. Dogu (Mersin, Turkey)

1:45pm-3:15pm

A longitudinal study of brain quantitative MRI analysis before and after diagnosis of progressive supranuclear palsy

K. Seo, T. Yamamoto, H. Kawasaki, A. Miyake, T. Hukuoka, Y. Nakazato, T. Takahasi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

1:45pm-3:15pm

A panel of CSF and plasma biomarkers reveals novel biological insights into atypical parkinsonian syndromes

E. Jabbari, J. Woodside, N. Magdalinou, A. Lees, H. Zetterberg, H. (London, United Kingdom)

1:45pm-3:15pm

A Young Man with Multiple System Atrophy: A Case Report

DR. Carneiro, M. Sousa, C. Januário, A. Morgadinho (Coimbra, Portugal)

1:45pm-3:15pm

Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)

A. Shoeibi, I. Litvan, J. Juncos, Y. Bordelon, D. Riley, S. Reich, D. Shprecher, D. Hall, C. Marras, B. Kluger, N. Olfati, J. Jankovic (Mashhad, Islamic Republic of Iran)

1:45pm-3:15pm

Affective impairment and emotional tone of early Richardson’s syndrome and Progressive Supranuclear Palsy with predominant parkinsonism: The role of Alexithymia and Anhedonia

C. Pellicano, F. Assogna, L. Cravello, C. Savini, M. Pierantozzi, A. Stefani, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

1:45pm-3:15pm

Amyotrophic Lateral Sclerosis-Progressive Supranuclear Palsy Phenotype with Negative C9ORF72 Mutation

S.C. Low, A.H. Tan, M. Ellis, K.J. Goh, S.Y. Lim, A. Ahmad-Annuar, N. Shahrizaila, M. Kennerson (Kuala Lumpur, Malaysia)

1:45pm-3:15pm

An atutopsy case of argyrophilic grain disease, clinically presenting with Parkinson dementia

R. Sengoku, D. Kaneda, M. Kameyama, A. Tokumaru, K. Ishii, K. Kanemaru, Y. Saito, S. Murayama (Tokyo, Japan)

1:45pm-3:15pm

Analysis of Tau Burden and Distribution on the Spectrum of PSP Subtypes

J. Sanchez-Ruiz Gordoa, P. Clavero, M. Zelaya, C. López-Molina, A. Galbete, V. Coca, M. Mendioroz, E. Erro (Pamplona, Spain)

1:45pm-3:15pm

Apolipoprotein E and multiple system atrophy

K. Ogaki, Y. Martens, M. Heckman, S. Koga, L. Labbé, O. Lorenzo-Betancor, A. Wernick, R. Walton, A. Soto, E. Vargas, H. Nielsen, S. Fujioka, T. Kanekiyo, R. Uitti, J. van Gerpen, W. Cheshire, Z. Wszolek, P. Low, W. Singer, N. Hattori, D. Dickson, G. Bu, O. Ross (Tokyo, Japan)

1:45pm-3:15pm

ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)

1:45pm-3:15pm

Assessment of CSF biomarkers clinical value in Progressive Supranuclear Palsy

T. Schirinzi, G. Sancesario, G. Di Lazzaro, N. Mercuri, S. Bernardini, A. Lang, A. Pisani (Rome, Italy)

1:45pm-3:15pm

Association of impaired melatonin secretion with sleep disturbance in multiple system atrophy

T. Nakamura, M. Ueda, M. Suzuki, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

1:45pm-3:15pm

Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)

1:45pm-3:15pm

Atypical Response to Apomorphine in a Patient with Multiple System Atrophy

S. Ozben, F. Genc, F. Tuter Yilmaz, A. Erdal, N. Atis (Antalya, Turkey)

1:45pm-3:15pm

Background pathology of ‘corticobasal degeneration (CBD) mimics’ -Japanese validation study of CBD (J-VAC study)

T. Shimohata, I. Aiba, M. Yoshida, Y. Toyoshima, S. Murayama, T. Uchihara, T. Arai, Y. Saito, H. Takigawa, K. Hasegawa, T. Ikeuchi, M. Hasegawa, T. Komori, K. Wakabarashi, A. Tokumaru, K. Sakurai, K. J-VAC study (Gifu, Japan)

1:45pm-3:15pm

Burden among Patients with Progressive Supranuclear Palsy

T. Xie, X. Ye, L. Kandukuri, Y. Bao (Chicago, IL, USA)

1:45pm-3:15pm

Burden of progressive supranuclear palsy: A systematic literature review

S. Chen, I. Jakab, T. Zelei, L. Szilberhorn, R. Bendes, B. Elezbawy, Z. Kaló, M. Mann, M. Potashman, J. Pitter (Cambridge, MA, USA)

1:45pm-3:15pm

Cerebellar signs in progressive supranuclear palsy

D. Crosiers, A. Sieben, J. Baets, J.J. Martin, P. Cras (Edegem, Belgium)

1:45pm-3:15pm

Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)

Y. Compta, S. Dias, M. Pulido-Salgado, D. Giraldo, A. Pérez-Soriano, M. Fernández, A. Cámara, P. Bravo, E. Muñoz, J. Saura, MJ. Marti (Barcelona, Spain)

1:45pm-3:15pm

Characterizing the spectrum of Non-motor Symptoms in Progressive Supranuclear Palsy

C. S P, V. Holla, S. Prasad, A. Stezin, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

1:45pm-3:15pm

Clinical features and natural history of pathologically-confirmed corticobasal degeneration: A Japanese validation study of CBD (J-VAC study)

I. Aiba, T. Shimohata, S. Murayama, K. Hasegawa, Y. Iwasaki, O. Yokota, H. Fujimura, M. Sakai, T. Yokota, I. Yabe, H. Takigawa, K. Sugaya, K. Mori, M. Ito, C. Ishida, M. Kobayashi, Y. Hashizume, T. Ikeuchi, M. Hasegawa, M. Yoshida, T. Komori, K. Wakabayashi, Y. Saito, A. Tokumaru, K. Sakurai, K. Nakashima (Nagoya, Japan)

1:45pm-3:15pm

Clinical spectrum of vascular Parkinsonism: A hospital-based study in south India

J. Kuragala, J. Murthy, N. Chaudhary, s. Sharma, S. Jaiswal, Y. Reddy (Anantapur, India)

1:45pm-3:15pm

Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

R. Ojha, K. Oli (Kathmandu, Nepal)

1:45pm-3:15pm

Comparative study of non-motor symptoms in patients with progressive supranuclear palsy and age, gender, duration of illness matched patients with Parkinson’s disease

V. Holla, C. SP, A. Lenka, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

1:45pm-3:15pm

Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes

A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, I. Illán, I. Aracil, J. Pérez-Pérez, B. Pascual, H. Bejr-Kasem, J. Marin, F. Sampedro, M. Botí, C. Izquierdo, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

1:45pm-3:15pm

Corticobasal Syndrome: A Single Center Case Series

M. Siddiqui, C. Goas (Winston Salem, NC, USA)

1:45pm-3:15pm

Deep brain stimulation in a patient with Spinocerebellar ataxia type 2 presenting as Parkinson’s disease: A case report

J. Im, Y. Lee, S. Paek, B. Jeon (Seoul, Republic of Korea)

1:45pm-3:15pm

Diffusion magnetic resonance imaging for predicting the severity of Progressive supranuclear palsy

X.A. Zhao, S.H. Lin, C.C. Tsai, Y.M. Wu, W.Y. Lin, Y.H. Weng, L.S. Lu, Y.L. Chen, J.J. Wang (Taoyuan City, Taiwan)

1:45pm-3:15pm

Disease progression and survival of multiple system atrophy: A prospective French cohort study

A. Foubert-Samier, A. Pavy-Letraon, F. Guillet, C. Helmer, M. LeGoff, F. Tison, F. Rascol, C. Proust-Lima, W. Meissner (Bordeaux, France)

1:45pm-3:15pm

Effects of mannitol treatment in a mice model of multiple system atrophy (MSA)

N. Lev, Y. Barhum (Kfar Saba, Israel)

1:45pm-3:15pm

Effects of multi-session repetitive transcranial magnetic stimulation on performance of motor control and dynamics of spontaneous brain activity in multiple system atrophy

Z. Liu, H.Z. Ma, X.M. Wang, Z. Wang, Y.Q. Wang, J.H. Zhou, T. Feng (Beijing, China)

1:45pm-3:15pm

Evolution of diagnostic certainty and PSP-predominance types in 187 pathologically confirmed PSP patients

M. Grimm, G. Respondek, I. Piot, T. Arzberger, Y. Compta, E. Englund, L. Ferguson, E. Gelpi, A. Giese, S. Roeber, D. Irwin, W. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, C. Troakes, G. Höglinger (Munich, Germany)

1:45pm-3:15pm

Expanding the NINDS Parkinson’s Disease Biomarkers Program – Utilizing a Major Biomarker Resource to Address Atypical Parkinsonisms and Related Conditions

C. Lungu, K. Arce, D. Babcock, K. David, BA. Sieber, C. Swanson-Fischer, M. Sutherland (Rockville, MD, USA)

1:45pm-3:15pm

Immunological causes of atypical parkinsonism

M. Cesarini, J. Etcheverry, G. Da Prat, G. Rojas, N. Gonzalez Rojas, E. Gatto (La Plata, Argentina)

1:45pm-3:15pm

Influence of Wearing Empty Backpack on Gait and Balance in Patients with Degenerative Parkinsonian syndrome

S. Lee, D. Heo, J. Park (Bucheon, Republic of Korea)

1:45pm-3:15pm

Is safinamide useful for atypical Parkinsonian syndromes?

M. Machío Castelló, M. Oses Lara, C. Feliz Feliz, J. del Val, P. García Ruiz (Madrid, Spain)

1:45pm-3:15pm

Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications?

N. Sawal, P. Bansal, R. Gupta (Chandigarh, India)

1:45pm-3:15pm

Midbrain Diameter Measurements on High-Resolution Computer Tomography Scans to aid diagnosis of Progressive Supranuclear Palsy

S. Potluri, C. Gan, C. Thomas, B. Mohamed, S. Schwarz (Cardiff, United Kingdom)

1:45pm-3:15pm

Midbrain/pons area ratio and clinical features predict the prognosis of PSP

S. Cui, S. Chen (Shanghai, People’s Republic of China)

1:45pm-3:15pm

Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies

ME. Avale, SL. Espindola, A. Damianich, M. Sartor, J. Ferrario (Buenos Aires, Argentina)

1:45pm-3:15pm

Movement disorders after stroke in the third Moroccan level hospital, Marrakech

A. Chahidi, M. Chraa, N. Kissani (Marrakech, Morocco)

1:45pm-3:15pm

MRI volumetrics in parkinsonian syndromes

K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)

1:45pm-3:15pm

MSA Preliminary Panamerican Report

M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)

1:45pm-3:15pm

Nilotinib for treating MSA: A preclinical proof of concept study

P. Guerin, M. Lopez-Cuina, E. Bezard, W. Meissner, P-O. (Bordeaux, France)

1:45pm-3:15pm

Non-motor symptoms in patients from the Catalonian Multiple System Atrophy Registry (CMSAR)

D.M. Giraldo, A. Pérez Soriano, J. Rios Guillermo, E. Muñoz, Y. Compta, J. Pagonabarraga, F. Valldeoriola, J. Hernández-Vara, S. Jauma Classen, V. Puente, C. Pont, N. Caballol, E. Tolosa, A. Bayes, J. Campdelacreu, O. Fabregues, A. Avila, M. Calopa, C. Gaig, N. Fabregat, P. Pastor, M. Aguilar, M. Pujol, L. Planellas, A. Camara, M.J. Marti (Barcelona, Spain)

1:45pm-3:15pm

Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

1:45pm-3:15pm

Olfactory testing in Parkinson plus syndromes

O. Abdukarimov, F. Akhmedova (Tashkent, Uzbekistan)

1:45pm-3:15pm

Palliative Virtual Home Visits for Atypical Parkinsonian Disorders (PVH-Park Study)

M. Afshari, A. Butala, J. Guenther, A. Pantelyat, N. Galifianakis (San Francisco, CA, USA)

1:45pm-3:15pm

Patient Perspective in Multiple System Atrophy

A. Mahajan, Z. Mari (Detroit, MI, USA)

1:45pm-3:15pm

PBT434 prevents the accumulation of glial cell inclusions and insoluble alpha-synuclein in a mouse model of Multiple System Atrophy

D. Finkelstein, P. Adlard, N. Stefanova, D. Stamler (Parkville, Vic, Australia)

1:45pm-3:15pm

Peripheral immune activation was associated with multiple system atrophy

B. Cao, XP. Chen, WH. Feng, QQ. Wei, LY. Zhang, HF. Shang (Chengdu, China)

1:45pm-3:15pm

Postural deformities in Chinese patients with multiple system atrophy

L. Zhang, B. Cao, Y. Zou, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shanng (Chengdu, China)

1:45pm-3:15pm

Prevalence of REM sleep behavior disorder and sleep-disordered breathing in multiple system atrophy: A meta-analysis

SL. Wu, CS. Chuang (Changhua, Taiwan)

1:45pm-3:15pm

Probable MSA presenting initially with urinary retention

S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

1:45pm-3:15pm

Progressive Supranuclear Palsy and Eye of the Tiger Sign

O. Dogu, H. Genç, N. Öksüz (Mersin, Turkey)

1:45pm-3:15pm

PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

J. Levin, S. Maass, M. Schuberth, A. Giese, W. Oertel, W. Poewe, C. Trenkwalder, G. Wenning, U. Mansmann, M. Suedmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Loehle, J. Classen, A. Muenchau, J. Kassubeck, G. Ebersbach, D. Berg, S. Egert, C. Eberhardt, F. Paul, K. Boetzel, B. Ertl-Wagner, H. Huppertz, I. Ricard, G. Hoeglinger (Munich, Germany)

1:45pm-3:15pm

Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy

K.W. Park, EJ. Lee, N.R. Choi, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

1:45pm-3:15pm

Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)

1:45pm-3:15pm

Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults

R. von Coelln, R. Dawe, J. Shulman, L. Yu, S. Leurgans, J. Hausdorff, L. Shulman, D. Bennett, A. Buchman (Baltimore, MD, USA)

1:45pm-3:15pm

Rapamycin for treating MSA: A preclinical proof of concept study

M. Lopez-Cuina, P. Guerin, E. Bezard, W. Meissner, P-O. Fernagut (Bordeaux, France)

1:45pm-3:15pm

Referral and diagnostic time intervals from symptom onset to death in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Parkinson’s disease (PD)

D. Swallow, C. Counsell (Aberdeen, United Kingdom)

1:45pm-3:15pm

Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report

S. El-Jaafary, A. Sabbah, S. Ahmed (Cairo, Egypt)

1:45pm-3:15pm

Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

J. Massa, L. Chahine (Pittsburgh, PA, USA)

1:45pm-3:15pm

Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome

T. Modi, M. Goyal, J. Kaur, B. Medhi (Chandigarh, India)

1:45pm-3:15pm

Serum cholesterol level is associated with risk of MSA

YC. Lu, MC. Kuo, RM. Wu (Taipei, Taiwan)

1:45pm-3:15pm

Serum fractalkine levels in Parkinson’s disease: Evidence for neuroinflammation

G. Nagesh Babu, M. Gupta, V. Paliwal (Lucknow, India)

1:45pm-3:15pm

Serum insulin-like growth factor-1 levels in parkinsonism or dementia disorders

K. Suzuki, S. Suzuki, Y. Ishii, T. Matsubara, H. Fujita, Y. Watanabe, M. Okamura, T. Kadowaki, H. Sakuramoto, K. Hirata (Tochigi, Japan)

1:45pm-3:15pm

Spatial correlation and segregation of multimodal MRI abnormalities in multiple system atrophy

J.H. Lee, M.J. Lee, T.H. Kim (Yangsan-si, Gyeongsangnam-do, Republic of Korea)

1:45pm-3:15pm

Striatal FP-CIT SPECT findings for progressive supranuclear palsy subtypes

M. Yogo, M. Morita, M. Suzuki (Tokyo, Japan)

1:45pm-3:15pm

The Catalonian Multiple System Atrophy Registry (CMSAR): The motor features and their impact on disability status in MSA patients

A. Perez-Soriano, DM. Giraldo, J. Rios-Guillermo, E. Muñoz, Y. Compta, MJ. Marti, On-behalf-of-Catalonian-MSA-Registry (Barcelona, Spain)

1:45pm-3:15pm

The characteristic of gait in progressive progressive supranuclear palsy

Y. Takamatsu, N. Matsuda, I. Aiba (Kyoto, Japan)

1:45pm-3:15pm

The clinical spectrum of motor stereotypies in progressive supranuclear palsy: An early, frequent and underestimated symptom

J. Pagonabarraga, A. Horta-Barba, I. Illan, I. Aracil, H. Bejr-Kasem, J. Pérez-Pérez, J. Marín-Lahoz, B. Pascual-Sedano, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

1:45pm-3:15pm

The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, T. Gurevich, A. Orr-Urtreger, N. Gilad, N. Bregman (Tel Aviv, Israel)

1:45pm-3:15pm

The role of deep brain stimulation targeting GPi in patients with multiple system atrophy

P. Hedera, D. Claassen, D. Isaacs (Nashville, TN, USA)

1:45pm-3:15pm

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy

P. Huang, H.Y. Zhou, Y.Y. Tan, S.D. Chen (Shanghai, China)

1:45pm-3:15pm

The Timed Up & Go test (time) is inversely associated with fall frequency in progressive supranuclear palsy

N. Matsuda, Y. Takamatsu, I. Aiba (Nagoya, Japan)

1:45pm-3:15pm

Toxin-induced Parkinsonism: A report of two patients

Z. Aldaajani (Dhahran, Saudi Arabia)

1:45pm-3:15pm

Unusual prolonged survival in multiple system atrophy: A case report

DM. Giraldo, A. Garrido, C. Simonet, J. Saavedra, Y. Compta, M. Marti, E. Tolosa, F. Valldeoriola (Barcelona, Spain)

1:45pm-3:15pm

Usefulness of combined examination using Frontal Assessment Battery (FAB) and Single Photon Emission Computer Tomography in the differentiation of 4 repeats (4R) tauopathic atypical parkinsonism

P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

1:45pm-3:15pm

Utility of Acute Levodopa Challenge Test In Early Parkinsonism

M. Acharya, A. Biswas, G. Ganguly, S. Das (Kolkata, India)

1:45pm-3:15pm

Vascular parkinsonism: Clinical features and comparison with Parkinson’s disease

C. Simonet, A. Garrido, F. Valldeoriola, MJ. Martí, Y. Compta (Barcelona, Spain)

1:45pm-3:15pm

What activities increase the risk of falling in atypical parkinsonian syndromes? A comparative study with Parkinson’s disease

P. Panyakaew, N. Kantachadvanich, S. Chaiwong, R. Bhidayasiri (Bangkok, Thailand)